Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00167180 · OUTCOME

Number of Patients Alive

Post Transplant Donor Lymphocyte Infusion · Source last updated 2019-07-30

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
COUNT_OF_PARTICIPANTS
Unit
Participants
Interval / dispersion
Not reported
Time frame
1 Year

What was measured

The percentage of people in a study or treatment group who are alive for a certain period of time after they were diagnosed with or treated for a disease, such as cancer. Also called survival rate. Overall survival will be defined as time from date of enrollment to date of death or censored at the date of last documented contact for patients still alive.

Groups in this outcome

DLI Cell Dose of 1.0 x 10^8 CD3+ T-cells/kg

Cyclophosphamide 60mg/kg IV over 2 hours Fludarabine 25 mg/m2 IV over 30 minutes DLI Cell Dose 1.0 x 10\^8 CD3+ T-cells/kg

DLI Cell Dose of 0.5 x 10^8 CD3+ T-cells/kg

Cyclophosphamide 60mg/kg IV over 2 hours Fludarabine 25 mg/m2 DLI Cell Dose 0.5 x 10\^8 CD3+ T-cells/kg

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
DLI Cell Dose of 1.0 x 10^8 CD3+ T-cells/kg15
DLI Cell Dose of 0.5 x 10^8 CD3+ T-cells/kg42

Reported measurements

Source class 1
Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
DLI Cell Dose of 1.0 x 10^8 CD3+ T-cells/kg3Not reportedNot reportedNot reportedNot reported
DLI Cell Dose of 0.5 x 10^8 CD3+ T-cells/kg20Not reportedNot reportedNot reportedNot reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        value
        3
      2. group Id
        OG001
        value
        20
denoms
  1. counts
    1. group Id
      OG000
      value
      15
    2. group Id
      OG001
      value
      42
    units
    Participants
description
The percentage of people in a study or treatment group who are alive for a certain period of time after they were diagnosed with or treated for a disease, such as cancer. Also called survival rate. Overall survival will be defined as time from date of enrollment to date of death or censored at the date of last documented contact for patients still alive.
groups
  1. description
    Cyclophosphamide 60mg/kg IV over 2 hours Fludarabine 25 mg/m2 IV over 30 minutes DLI Cell Dose 1.0 x 10\^8 CD3+ T-cells/kg
    id
    OG000
    title
    DLI Cell Dose of 1.0 x 10^8 CD3+ T-cells/kg
  2. description
    Cyclophosphamide 60mg/kg IV over 2 hours Fludarabine 25 mg/m2 DLI Cell Dose 0.5 x 10\^8 CD3+ T-cells/kg
    id
    OG001
    title
    DLI Cell Dose of 0.5 x 10^8 CD3+ T-cells/kg
param Type
COUNT_OF_PARTICIPANTS
reporting Status
POSTED
time Frame
1 Year
title
Number of Patients Alive
type
PRIMARY
unit Of Measure
Participants

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice